Institutional Capital Arrives to Advance European Cannabis

With a population over 740 million and a total cannabis market estimated to be worth up to €123 billion by 2028, Europe is on track to become one of the world’s largest legal cannabis markets within the next five years. In fact, over €500 million has already been invested in European cannabis businesses to date.

Since the multijurisdictional nature of Europe makes it a complex market, this panel will focus on lessons learned from the established regulated markets as industry players look for advantageous opportunities to advance European cannabis.

Host, Paul Rosen, Executive Chairman, Global Go

Rosen is an early pioneer in the globalized cannabis industry, having been a co-founder of PharmaCan Capital Corp (now Cronos Group) and served as its first CEO and President. Under Rosen’s leadership, PharmaCan/Cronos Group acquired ownership interests in a number of the initial cannabis licenses awarded in Canada and was the 3rd cannabis company to go public in Canada. Rosen sat on the board of iAnthus Capital Holdings, a multistate operator of cannabis assets in the United States and has advised and/or invested in more than 150 companies in the cannabis industry.

Keynote, Antonio Costanzo, Co-Founder & CEO, EMMAC Life Sciences

Antonio Costanzo is the CEO and co-founder of EMMAC Life Sciences, the leading European cannabis company. Before EMMAC, Antonio co-founded and was Head of International Development at Nuuvera, a publicly listed Canadian cannabis corporation. Prior to focusing on the cannabis industry, he was Head of Public Policy and Government Relations at Uber.

He formerly spent 10 years in the online gaming industry, at bwin, as Director of International development and Regulatory Affairs.

He served for 5 years as vice-Chairman and board Director at ESSA – Sport Betting Integrity.

Before joining bwin he was Head of Editorial Development Italy for the Eurosport Group and worked on the conception and creation of Sportitalia, the first free-to-air terrestrial all-sport television network in Italy.

He has invested in multiple successful ventures in the tech, gaming and fintech space.

Moderator, Janet Jackim, Partner, Zuber Lawler & Del Duca LLP

Janet Jackim, who received the AV-Preeminent® Rating from Martindale-Hubbell®, focuses on real estate acquisitions and leasing; equity and debt financing; loan workouts; and cannabis acquisitions, dispositions, and other deals. Ms. Jackim supplements her legal insight with advanced technical, operational and financial acumen particular to the cannabis industry. Her problem-solving creativity aids in resolving complex issues for her rapidly expanding cannabis clients.

Ms. Jackim is particularly well-versed in cannabis litigation. She has handled the acquisition of cannabis operations across the nation. Her expertise in cannabis law has allowed her to represent clients in diverse topics including matters relating to cannabis dispensary certificate applications, buyout transactions, business restructuring, and partner dispute resolution. Ms. Jackim’s cannabis clients include multistate operators, dispensaries, producers, cultivators, investors, lenders, landlords, tenants, and vendors.

Ms. Jackim is based in Phoenix and serves on the Board of Directors of Arizona Cannabis Chamber of Commerce; on the Legal Committee of the National Organization for the Reform of Marijuana Laws (NORML); as Secretary of the Arizona Cannabis Bar Association; and, until recently, was a Co-Chair of the Meritas Cannabis Practice Steering Committee of North America, working with law firm affiliates across the United States.

Panelist, Kingsley Wilson, Partner, Chrystal Capital Partners

Kingsley has worked in the regulated financial and investment services industry for over 24 years, spending 10 years as a capital markets research analyst focused on company analysis, portfolio construction and risk mitigation. He has spent the past 14 years advising companies on raising more than $1.5bn of capital across over 100 public and private transactions.  Kingsley co-founded Chrystal Capital Partners in 2009 with James Innes. Over the past four years, Kingsley has advised on multiple cannabis investments for various public and private companies, deploying over $210m across 10 cannabis transactions for 375 investors. He has established an extensive network of investor, advisor and company relationships across the cannabis industry and is a regular speaker at industry conferences given his deep industry knowledge and unique European perspective. Kingsley was educated at Cambridge University, before starting his investment banking career in London at Collins Stewart and Investec.

Panelist, Tjalling Erklens, Founder & CEO, Bedrocan

Tjalling Erkelens (1956) is the founder of Bedrocan and currently holds the position of Founder/CEO. Back in 1984 he started Bedrocan in the Netherlands together with his brother in law Freerk Bruining, focussing on indoor production of vegetables and herbs. Tjalling is strongly committed to maintain these family business roots especially now Bedrocan continues to grow.

The cannabis plant came into the company back in 1992 for the first time. Since 2003 Bedrocan provides standardised cannabis of pharmaceutical quality to the Dutch government. It’s the oldest legal company in the world providing several, chemically different cannabis varieties to be used by patients on doctor’s prescription and as a raw material for the pharmaceutical industry (API).

During these past 26 years, Tjalling has developed and standardised unique methods of producing cannabis to pharmaceutical standards to a level achieved by no other company until today. His strong commitment to product quality resulted in the Dutch Bedrocan production facilities being approved for GMP/API (Good Manufacturing Practice/Active Pharmaceutical Ingredients) by the Dutch Health Authorities in 2017.

“It is my strong belief that there should be a clear distinction between medicinal and recreational use of cannabis and that patient needs for safe and consistent cannabis is a priority”, Tjalling says when talking about the company’s mission and vision. He is convinced that this can be achieved by going through the formal drug approval process. “Only fully standardised medicinal cannabis is the foundation on which such approval can be achieved.”

Panelist, Joel Sherlock, Co-Founder & CEO, Vitalis Extraction Technology

A serial entrepreneur, investor, and born connector, Joel has built a career on pioneering new industries, building dynamic teams, and re-defining innovation. He has been at the helm of over 10 successful start-ups and corporate exits, including one of British Columbia’s top private real estate brokerages, a national first action sports e-commerce company, a successful corporate consulting firm, and several multi-million dollar private equity funds.

He is CEO, acting CRO, and Co-founder of British Columbia based, Vitalis Extraction Technology, an industry leader in manufacturing industrial supercritical CO 2 extraction equipment and recently ranked No. 3 for Canada’s Top Growing Companies. Joel is also Co-founder of Vancouver-based private equity fund, Doventi Capital, established to support professionals in the growing legal cannabis market. Having identified a need to support entrepreneurs and manufacturers in the world’s fastest-growing markets. Joel also manages Spectrum Leasing, an asset-backed lender based in Toronto.

Originally from Winnipeg, Manitoba, Joel’s early years were spent on the farm – a far cry from studying finance at the University of British Columbia and Harvard Business School. To this day, Joel loves to return to his Canadian roots to disconnect from the fast pace of entrepreneurship and reconnect with family and friends.

Panelist, Andrew Petronanos, Founder & CEO, FINELEAF and Global Go Switzerland

Andrew has been a team player, manager and founder within the gastronomy industry as well as part of technology start-ups and international companies in the fields of Engineering and Finance. He is focused on bridging this experience of working in diverse industries and in different countries to help others achieve their goals within the growing European Cannabis Market.

He brings on board a charismatic and strategic approach that any business would want to have on their side, but most importantly his success is within people at identifying, building and sustaining key relationships. His biggest belief is that business is always done within people, so his main focus is always to have long term relationships with the people you need and want to have in order to grow your company.

About Global Go  
Global Go provides sophisticated consulting services to the global cannabis and hemp industry.  In tandem with strategic allies around the world, Global Go serves clients throughout the world from offices in Bogota, Chicago, Johannesburg, London, Los Angeles, Mexico City, New York, Nicosia, Palm Springs, Phoenix, São Paulo, Silicon Valley, Toronto, and Zurich. Powered by a team of cannabis industry pioneers and world-class consultants, Global Go helps leading cannabis funds and companies assess and enter new markets; acquire assets; raise capital; launch new product lines; improve SOPs; comply with regulations; implement technology and security systems; find talent; diagnose and execute solutions to growth obstacles; and apply for cannabis licenses (with a 99% success rate on over 150 cannabis license applications across the United States).  Learn more at